Evidence map›Paper›PMID 36800187›Full record

ArticleJAMA2023

Stool-Based Screening Tests for Colorectal Cancer.

John M Carethers

2 registry-linked trialsAbstract read
In one paragraph

Article in JAMA, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06342440 recruitingnot on this map

A Liquid Biopsy Assay For The Non-Invasive Early Detection of Advanced Adenomas and Colorectal Cancer

TypeobservationalSponsorCity of Hope Medical CenterRan2020 to 2028Enrolled2,000ConditionsColorectal Cancer, Colorectal Neoplasms, Colorectal Polyp, Colorectal AdenocarcinomaArmsDENEB
NCT07450612 recruitingnot on this mapstarted 2024, after this paper: background citation

Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection

TypeobservationalSponsorSan Raffaele UniversityRan2024 to 2031Enrolled1,200ConditionsColorectal Cancer, Adenoma Colon, Adenoma Colon Polyp, Colon AdenomaArmsBEACON
3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. [Achievements and Future Directions of the National Colorectal Cancer Screening Program in Korea].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Commentary: Liquid Biopsy for Average-Risk Colorectal Cancer Screening.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024
    Article
  8. Improving Noninvasive Colorectal Cancer Screening.The New England journal of medicine · 2024
    Article
  9. THE JEREMIAH METZGER LECTURE: ENVIRONMENTAL INFLUENCES ON COLORECTAL CANCER.Transactions of the American Clinical and Climatological Association · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

John M CarethersDivision of Gastroenterology, Department of Medicine, University of California, San Diego.

Funding

Inactivation of MSH3 in Colorectal Cancer and RaceR01CA258519 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ASHKTORAB, HASSAN, CARETHERS, JOHN M · 2021 to 2025
$2.9M
NCI NIH HHS R01 CA258519
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colorectal NeoplasmsEarly Detection of CancerFecesColonoscopyHumansMass ScreeningOccult Blood

Identifiers

PMID36800187
PMCPMC10386850

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.